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 LDL, long established as the major plasma particle in the 
transport of lipids, is considered the chief causative agent in 
cardiovascular diseases. LDL particles have been the subject 
of extensive study ( 1–6 ) that focused on commonly recog-
nized properties of apo B100 as a lipid vector. A few “out-of-
the-box” studies in 1980s and early 1990s suggested that apo 
B100 is involved in signal transduction pathways ( 7, 8 ), in-
cluding regulation of immune response ( 9, 10 ). At present, 
numerous studies support a role for LDL in signaling ( 11–
15 ). The function of LDL as a transporter of viral materials, 
including nucleic acids, in the plasma was documented 
( 16–23 ); however, an explanation for this function at the 
molecular level has yet to be provided. 
 Low density particles composed of lipid, apo B100, RNA, 
and core protein of hepatitis C virus ( hcv ), termed lipo-
viro-particles, were reported in the plasmas of individuals 
infected with  hcv ( 17, 19, 21 ). These particles continue to 
be studied as a source of persistent, chronic infection. In 
addition, several reports have suggested that the  hcv and 
other  Flaviviridae viruses may negotiate cell entry via the 
 Abstract  LDL mediates transfection with plasmid DNA in 
a variety of cell types in vitro and in several tissues in vivo in 
the rat. The transfection capacity of LDL is based on apo 
B100, as arginine/lysine clusters, suggestive of nucleic acid-
binding domains and nuclear localization signal sequences, 
are present throughout the molecule. Apo E may also con-
tribute to this capacity because of its similarity to the Den-
gue virus capsid proteins and its ability to bind DNA. 
Synthetic peptides representing two apo B100 regions with 
prominent Arg/Lys clusters were shown to bind DNA. Re-
gion 1 ( 0014 Lys-Ser 0160 ) shares sequence motifs present in 
DNA binding domains of Interferon Regulatory Factors 
and  Flaviviridae capsid/core proteins. It also contains a 
close analog of the B/E receptor ligand of apo E. Region 1 
peptides, B1-1 ( 0014 Lys-Glu 0054 ) and B1-2 ( 0055 Leu-Ala 0096 ), me-
diate transfection of HeLa cells but are cytotoxic. Region 2 
( 3313 Asp-Thr 3431 ), containing the known B/E receptor ligand, 
shares analog motifs with the human herpesvirus 5 immedi-
ate-early transcriptional regulator ( UL122) and  Flaviviridae 
NS3 helicases. Region 2 peptides, B2-1 ( 3313 Asp-Glu 3355 ), 
and B2-2 ( 3356 Gly-Thr 3431 ) are ineffective in cell transfection 
and are noncytotoxic.  These results confi rm the role of 
LDL as a natural transfection vector in vivo, a capacity im-
parted by the apo B100, and suggest a basis for  Flaviviridae 
cell entry. — Guevara, J., Jr., N. Prashad, B. Ermolinksy, J. W. 
Gaubatz, D. Kang, A. E. Schwarzbach, D. S. Loose, and N. V. 
Guevara.  Apo B100 similarities to viral proteins suggest ba-
sis for LDL-DNA binding and transfection capacity.  J. Lipid 
Res . 2010. 51:  1704–1718. 
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 METHODS 
 Chemicals 
 All chemicals were of highest quality available. Water of 18.2 
M  ·cm resistivity was used throughout these studies. Tap water 
was passed through a mixed-resin fi lter, distilled, and fi ltered us-
ing a Barnstead E-pure system. Molecular biology grade Agarose 
was purchased from Fisher Scientifi c, Inc. PBS was obtained from 
MediaTech, Inc., Herndon VA, or other chemical suppliers. Tris-
acetate (TA) buffer, DNA sequence grade, was obtained from 
TECNOVA, Inc. Nucleic acid sample loading buffer was from 
Bio-Rad, Inc. BOBO1 TM -iodide (B-3582) and Cell Tracker™ CM-
DiI (C-7001) fl uorescence dyes, and Lipofectin TM were purchased 
from Invitrogen, Inc. Synthetic peptides, of 95% or greater purity 
by HPLC analysis, were purchased from GenScript, Corp.. Plas-
mid vectors, pCMV   -Gal, pEGFP-N1, and pEGFP-N2, were from 
ClonTech, Inc. Plasmids, phMGFP, pGL2-Control, pCMVTNT ® , 
and restriction enzymes  Stu I and  Hin dIII were obtained from 
Promega, Inc. Cell culture media, DMEM, and HyQ-RPMI 1640 
were obtained from MediaTech, Inc. and Thermo Fisher Scien-
tifi c, Inc. Transfection Reagent 1, DOTAP: DOPE (1:1) was pur-
chased from Avanti Polar Lipids, Inc. QIAamp DNA Mini kit was 
obtained from QIAGEN, Inc. PCR reagents were obtained from 
Roche Biochemicals, Inc. DNA Molecular Weight standards were 
purchased from Roche Applied Science, Inc. 
 Isolation of plasma lipoproteins 
 Human.  Highly purifi ed preparations of human plasma LDL 
were obtained from Invitrogen, Inc. and Athens Research and 
Technology, Athens, GA. LDL was also isolated from human 
plasma by sequential ultracentrifugation in NaBr solutions yield-
ing the 1.019–1.05 g/ml density range of LDL fraction ( 6 ). Single 
donor plasma with sodium EDTA added at time of collection was 
obtained from Innovative Research. Typically, purifi ed prepara-
tions of LDL were dialyzed in PBS containing 10 mM MgCl 2 . LDL 
was than evaluated for purity using SDS-PAGE, and tested for 
DNA binding capacity using electrophoretic mobility shift assay 
(EMSA). Once DNA binding capacity of the LDL preparation 
was confi rmed, it was frozen drop-wise in liquid nitrogen and 
stored in aliquots of about 200 µL in liquid nitrogen until needed. 
Highly purifi ed, delipidated apo E was purchased from Athens 
Research and Technology, Inc. 
 Rats.  Female Sprague-Dawley rats, 8–10 weeks old, were ob-
tained from Harland Laboratories, Inc. Animals were housed in 
the National Institutes of Health-accredited facilities in the Uni-
versity of Texas Health Science Center and Baylor College of 
Medicine. All animals were treated in accordance with the Guide 
for the Care and Use of Laboratory Animals published by the 
U.S. National Institutes of Health (NIH publication no. 85-23, 
revised in 1996). All animal protocols were approved by the Ani-
mal Welfare Committees at the University of Texas Health Sci-
ence and Baylor College of Medicine. 
 Rat plasma was used to purify LDL. To obtain blood, animals 
were fi rst sedated using inhalation anesthetic metaphane. This 
was followed by an injection of a combination anesthetic contain-
ing ketamine (42.8 mg/ml), xylazine (8.6 mg/ml), and acepro-
mazine (1.4 mg/ml) in PBS. Blood was then collected by heart 
puncture using a 5 ml syringe containing 50 µl of 100 mM EDTA. 
Approximately 4–5 ml of blood was collected per animal. Sam-
ples were pooled and centrifuged at 400 rpm for 20 min. LDL 
was isolated using equilibrium ultracentrifugation in preformed 
gradient of KBr. Collected plasma, 9–10 ml from six rats, was di-
luted to 12 ml with saline, then the density of the sample was ad-
justed to 1.21 g/ml with KBr. Plasma was transferred to centrifuge 
LDL B/E receptor ( 24, 25 ). These observations suggest 
possible links between LDL and viruses.  Flaviviridae are 
single-stranded RNA viruses with a genome that encodes 
three structural proteins (capsid/core C protein, precur-
sor membrane protein, and an envelope E protein) and 
seven nonstructural proteins (NS1, NS2A, NS2B, NS3, 
NS4A, NS4B, and NS5) ( 26 ). The genome is encapsulated 
in a sphere that includes multiple copies of the capsid/
core protein. It is therefore possible that an analog se-
quence of the B/E receptor ligand ( 27, 28 ) is present in 
the structural proteins of these viruses. 
 In previous reports, we showed that human LDL binds 
DNA and RNA in vitro ( 18, 20 ) and that highly purifi ed LDL 
can be used to transport and deliver plasmid DNA to the cell 
nucleus. We surmised that the capacity of LDL and VLDL to 
bind nucleic acids is likely based on the presence of regions 
in the apo B100 molecule that display sequence similarities 
to known nucleic acid-binding domains ( 29 ). Based on the 
location of arginine and lysine clusters and other motifs, fi ve 
potential DNA binding domains, 11 potential KH domains 
of the heterogeneous nuclear ribonucleoprotein K ( 30, 
31 ), and numerous bipartite nuclear localization signal se-
quences (NLS) were identifi ed in the apo B100 primary 
structure ( 18, 20 ). One candidate DNA-binding region is 
con tained in the fi rst 100 N-terminal residues of the apo 
B100. Several sequence motifs also present in the DNA-bind-
ing domains of interferon regulatory factors ( 29 ), the inter-
feron regulatory factor ( irf -s), are located in this region. 
 In this report, we explore the hypothesis that apo B100 
and apo E have structural and functional similarities to 
viral DNA-binding proteins. We focus on two candidate 
nucleic acid-binding regions: N-terminus of apo B100, res-
idues  0014 Lys-Ala 0096 (Region 1) and the section encompass-
ing the known B/E-receptor ligand of apo B100, res idues 
 3313 Asp-Thr 3431 (Region 2) (32,33). Sequences of these re-
gions are compared with viral nucleic acid-binding pro-
teins, the capsid/core proteins. The apo B100 Region 2 
sequence is compared with the NS3 proteins of the  Flavi-
viridae viruses [Dengue ( dng ), West Nile ( wnlv ), yellow fe-
ver ( ylfv ), and hepatitis C] ( 34, 35 ) and to UL122 protein 
from human cytomegalovirus (HCMV) ( 36 ). In addition, 
we expand our comparison of Region 1 to human  irf pro-
teins. Primary structure similarities strongly support these 
two regions of the apo B100 molecule as nucleic acid- 
binding domains in apo B100. We also analyze similarities 
between the receptor ligand region of apo E (Leu 151 -
Arg 278 ) and  dng capsid proteins and demonstrate DNA-
binding capacity of purifi ed apo E. Our hypothesis compels 
us to consider that LDL and LDL-related particles, inter-
mediate and very low density particles, are involved in 
transporting nucleic acids, and this capacity is imparted by 
specifi c regions of the apo B100 as well as apo E. 
 Here we present additional evidence that LDL and 
VLDL have the capacity to bind DNA. Further, LDL can be 
used to transfect a variety of cell types in vitro and in vivo. 
Based on the results of experimental studies utilizing syn-
thetic peptides from Regions 1 and 2 of apo B100, we con-
clude that this capacity is mediated by elements in the apo 
B100 primary structure similar to viral proteins. 
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plasmid DNA. CHO and NIH3T3 cells were grown on cover slips 
and transfected using LDL complexed to BOBO-1-pEGFP-N1 
DNA as described above, except LDL was not labeled. The cover 
slips were recovered at different periods and were inverted over 
on well slides containing PBS without paraformaldehyde treat-
ment. Cell images were obtained using a LUMAM TM EPI-Fluores-
cent microscope. Similarly, HeLa cells were grown in Costar® 
multi-well, fl at bottom polystyrene plates and transfected using 
solutions containing LDL complexed to BOBO-1-pCMVTNT 
DNA. Results of HeLa cell transfection were documented using a 
Zeiss Axiovert 25 microscope. 
 Nonlabeled LDL complexed to the nonlabeled pEGFP-N1 
plasmid was used to transfect HeLa, MCF 7, CHO, and NIH/3T3 
cell types as described above, and green fl uorescence protein 
(GFP) expression was documented using a LUMAM TM fl uores-
cence microscope with a GFP fi lter. 
 HeLa cells were used also to ascertain the transfection capacity 
of two sets of synthetic peptides. Cells were grown as routine, pre-
conditioned in FBS-free DMEM for 4 h, washed thrice with PBS, 
and 400 µl PBS supplemented with 10 mM MgCl 2 , containing ei-
ther the synthetic peptides or peptide/DNA complexes was 
added. Cells were incubated at 37°C as described in Methods for 
30 min, then washed, and Trypan Blue dye in PBS was added. 
 Noncovalent labeling of plasmid  DNA with BOBO-1 
 Labeling of DNA with BOBO-1™-iodide was accomplished ac-
cording to the methods described by the vendor (Molecular 
Probes dimeric cyanine nucleic acid stains) with minor modifi ca-
tion. Briefl y, 3 µl of 10 µM dye (1 mM stock solution diluted 1:100 
with ethanol) was added to 10   g of DNA at a concentration of 
0.5   g/  l in PBS, and the solution was incubated at ambient 
temperature for 1 h. 
 Labeling of Lipofectin TM and LDL with CM-DiI 
 Labeling of Lipofectin TM and LDL with Cell Tracker™ CM-DiI 
was performed according to the methods described by the vendor 
(Molecular Probes ). Transfection agents were labeled by adding 
1 µl of 20 µg CM-DiI/ml in ethanol (stock solution) to 100 µL of 
Lipofectin (undiluted reagent) or LDL (1.5 mg/ml by protein), 
and the mixture was incubated for 1 h at ambient temperature. 
Unreacted dye was removed using a Sephadex G-25 column. 
 Liposome preparation 
 Transfection Reagent 1 (10 mg, Avanti Polar Lipids, Inc.) was 
dissolved in 2 ml of a sterile buffer solution of 0.9% NaCl, 5.0% 
glucose, and 10% sucrose. The suspension was placed in a 37°C 
water bath for 10 min and vortexed to disperse the opaque lipid 
vesicles. Small unilamellar vesicles (SUV) were then formed by 
sonicating the mix for about 3 min. The transparent SUV mix 
was concentrated to approximately 11 mg/ml using an Amicon/
Microcon fi lter concentrator with a YM-3 membrane (Sigma, 
Inc.). The solution was then sterilized through a 0.22 micron fi l-
ter (Millipore, Inc.). 
 Transfection solutions 
 All LDL preparations used in this study were shown to bind 
DNA in EMSA prior to cell transfection experiments. Plasmids 
pCMV   -Gal, pEGFP-N1, pEGFP-N2, phMGFP, pGL2-Control, 
and pCMVTNT ® bound LDL in a similar manner. 
 LDL.  For cell transfection, purifi ed LDL was added to the 
microfuge tube containing DNA and PBS with 10 mM MgCl 2 . 
The mixtures were then incubated at 37°C for 30 min before use. 
Typically, 20–40 µg of LDL protein was complexed with 1.0 µg 
DNA. 
tubes of SW 40 Ti swinging bucket rotor (Beckman), 4 ml per 
tube, overlaid with KBr solutions of the following densities: 1.063 
g/ml (3.0 ml), 1.02 g/ml (3.0 ml), and 1.006 g/ml (2.5 ml). Sam-
ples were next centrifuged at 39,000 rpm for 60 h at 4°C. Seven 
fractions were collected from each tube, starting from the top of 
the centrifuge tube, and similar fractions from different centri-
fuge tubes were pooled then dialyzed against PBS. Protein con-
centration was routinely determined using modifi ed Lowry 
method ( 18 ), and SDS-PAGE (2–12%) was performed. LDL frac-
tion was identifi ed by presence of apo B100 band. 
 EMSA 
 An aliquot of plasmid DNA digested using restriction enzymes 
was placed at the bottom of a microfuge tube; next, a buffer solu-
tion containing 25 mM TA, pH 7.6, and 10 mM MgCl 2 was added. 
An aliquot of purifi ed lipoprotein (LDL, VLDL, apo E) or syn-
thetic peptides was then added; the cocktail was stirred gently for 
less than 5 s and incubated for 30 min at 37°C. Sample loading 
buffer (Bio-Rad) was then added at a 1:5 (v/v) ratio to the poly-
peptide-DNA mix. Next, each sample was mixed and subjected to 
electrophoresis using 0.5–0.8% agarose gels in TA buffer at 100 
V. Aliquots of nucleic acid, synthetic peptides, and lipoprotein 
were each analyzed in separate lanes as controls. DNA bands 
were visualized using ethidium bromide. Peptides and proteins 
in lipoprotein particles were visualized using Coomassie brilliant 
blue R-250 (CBB). 
 Cells 
 All cell types used in these studies were obtained from the 
American Type Culture Collection Organization. Cells were kept 
in liquid nitrogen until needed and then grown according to 
American Type Culture Collection protocols. 
 Several cell types, NIH/3T3 (mouse embryonic fi broblast cell 
line, CRL-1658™), CHO (chinese hamster ovary, CCL-61™), 
MCF7 (human breast adenocarcinoma cell line, HTB-22™), Hep 
G2 (human hepatocyte carcinoma cells, HB-8065™), and HeLa 
(human cervix epithelial adenocarcinoma cell line, CCL-2™), 
were used for LDL- and apo B100 synthetic peptide-mediated 
transfection. Cells were grown and maintained in media as 
follows: HeLa, Hep G2, MCF7, and NIH/3T3 cell types were 
in DMEM supplemented with 10% FBS, 100 units penicillin 
G-sodium, 100 units/ml streptomycin sulfate, and 250 ng/ml am-
photericin B. CHO cells were in RPMI-1640 containing 10% FBS, 
 L -glutamine, and 100 units penicillin G-sodium, 100 units/ml 
streptomycin sulfate, and 250 ng/ml amphotericin B. Cells were 
maintained at 37°C in an atmosphere of 5% CO 2 in a humidifi ed 
incubator. Typically, cells were grown in culture plates (with or 
without glass cover slip in wells) to 60–70% confl uence ( 20 ). 
Prior to transfection, the medium was removed, and cells were 
washed thrice with PBS. Cells were then incubated for a mini-
mum of 2 h but not more than 4 h in FBS-free medium. 
 Dual label experiments were conducted using Hep G2 cells. 
The cells were grown overnight as described above on FBS-coated 
cover slips to enhance attachment. Cells were next washed with 
PBS and incubated in FBS-free medium for 4 h, then incubated 
for 3 h in 200 µl of transfection solution containing FBS-free 
DMEM, 10 mM MgCl 2 , and preformed complexes of BOBO-1- 
labeled pCMV   -Gal plasmid DNA (3 µg), and either 15 µL of 
CM-DiI-labeled Lipofectin TM or 60 µg of CM-DiI-labeled LDL. The 
cell-coated cover slips were then removed, washed in PBS, and 
fi xed in 4% paraformaldehyde for 10 min at 4°C. Each cover slip 
was then inverted over a well of a hanging drop slides containing 
PBS and viewed using an Olympus Model BH-2 fl uorescent 
microscope. 
 Similar methods were used to study LDL-mediated transfec-
tion of CHO, NIH3T3, and HeLa cells using BOBO-1-labeled 
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closed with a wound clip. All animals were injected with mixtures 
containing 200 µg of pGL2-Control plasmid DNA (Promega, 
Inc.). The control animal, rat1, was injected DNA in Tris-EDTA 
buffer. Test rat2 was injected with pGL2-Control complexed with 
LDL (1:5) in 10 mM Tris (pH 7.5), 40 mM NaCl, 1 mM EDTA, 1 
mM DTT, and 4% glycerol. Rat3 was injected with pGL2-Control 
complexed with the liposome (1:10, as described above) and rat4 
was with cocktail composed of pGL2-Control: LDL: liposome 
(1:1:7). Animals were anesthetized with ketamine/xylazine and 
decapitated 24 h after the transfection injections were adminis-
tered. Tissue samples were collected from heart, lung, liver, 
brain, kidney, and spleen, weighed, and immediately frozen in 
liquid nitrogen. Liquid N 2 was added to the sample (25 mg of 
each tissue, except 10 mg of spleen was used) in a cold mortar 
and ground to a fi ne powder using a chilled pestle. Tissues were 
digested with Proteinase K for 24 h at 56°C; DNA was then 
extracted from each tissue using the QIAamp DNA Mini kit 
(QIAGEN, Inc.) as described in the QIAGEN Handbook of Pro-
tocols. Presence of the luciferase gene was confi rmed via PCR 
using reagents from Roche Biochemicals, Inc., and a primer set, 
5 ′ agcaactgcataaggctatg and 3 ′ gttggtactagcaacgcact obtained from 
Genosys Biotechnologies, Inc. Reactions were performed in a 
Perkin Elmer DNA Thermal Cycler Model 480. 
 Fluorescent microscopy 
 Microscopy of Hep G2 cells and animal frozen tissue sections 
was performed using an Olympus model BH-2 fl uorescence 
microscope equipped with a Hamamatsu 3 CCD model C5810 
camera. The LUMAM TM EPI-Fluorescence microscope (LOMO 
America, Inc.) equipped with an Optronics MacroFire® 2.0 CCD 
camera and the Zeiss Axiovert 25 microscope with the Optronics 
MicroFire CCD camera were used to obtain all other cell images. 
The following fi lter sets were used: a fl uorescein (FITC/TRITC) 
no. 51004V2 cube, a Chroma HQ-GFP NB 710 cube no. 41020 
(Chroma Technology, Brattleboro, VT), and an Olympus di-
chroic DM500 (BP490) fi lter. 
 Image processing 
 Adobe Photoshop CS version 8 software and full-frame images 
of the same fi eld of view of equal size and dimensions were used to 
create merged overlay images. Images obtained at emission spec-
trum of 505–515 nm were used as background, and bright light 
images or red region images were overlaid at 50% transparency. 
 Sequence alignment 
 Selection of protein sequences was based on the association of 
LDL/VLDL and  Flaviviridae viruses ( 24, 25 ) in human plasma, ob-
servations regarding colocation of apo B100 and HCMV DNA in 
arterial wall ( 37, 38 ), our previous reports on the similarity of apo 
B100 to  irf proteins, and on preferential binding of LDL to CMV 
promoter-containing plasmids ( 20 ). The apo E LDL receptor li-
gand sequence spanning residues Leu 151 to Arg 278 was also in-
cluded. All protein sequences were obtained from the National 
Institutes of Health protein database and saved as simple text doc-
uments. The capsid protein sequences for  dng versions 1–4,  hcv , 
 wnlv ,  ylfv virus, bovine viral diarrhea virus, and NS3 helicase se-
quences were obtained from their respective polyprotein fi les in 
the same database. Rather than identifying all clusters of group-
related amino acids, we fi rst focused our efforts on two types of 
clusters. The letter symbols for amino acids arginine (R), lysine 
(K), histidine (H), proline (P), cysteine (C), and glycine (G) were 
highlighted in each protein sequence fi le to locate basic amino 
acid clusters such as the apo E LDL receptor ligand “RKXRKR”, 
and motifs common to nucleic acid binding domains as well as 
structurally important motifs such as “PG” and “GXXG”. Se-
 Lipofectin TM .  Ten microliters of reagent in 100 µl culture me-
dium was combined with 100 µl culture medium containing 10 
µg DNA. The solution was then stirred gently and incubated for 
at least 30 min at room temperature. 
 Liposome.  Transfection Reagent 1 was prepared as described 
above. The SUV preparation was combined with plasmid DNA 
(10:1) in TE buffer and incubated at ambient temperature for 
5 min before use. 
 Synthetic peptides.  Amino acid sequences of the peptides are 
listed in  Table 1 (Region 1) and  Table 3 (Region 2). Peptides 
were received in lyophilized form and 1 mg/ml solutions were 
prepared in PBS/10 mM MgCl 2 by vortexing. Solutions were fro-
zen drop wise in liquid nitrogen and stored at   80°C until use. 
Aliquots were thawed and sterilized using a 0.2 micron fi lter im-
mediately prior to use. In EMSA, plasmid DNA was mixed with 3, 
6, and 12 µg of peptide individually or in a mixture representing 
a region of apo B100. Peptides were fi rst mixed in equal amounts 
(v/v) and incubated at 37°C for 30 min. The peptide mix was 
then added to the DNA in a microtube after which PBS/MgCl 2 
buffer was added and the cocktail was mixed by repeated drawing 
into the pipette tip. 
 Animal transfection experiments 
 Two separate animal studies were conducted. In one study at 
Baylor College of Medicine, 12 rats were used to determine GFP 
expression in different tissues after human LDL- and rat LDL-
mediated transfection. Prior to transfection, both human LDL and 
rat LDL were shown to bind DNA in a similar manner using EMSA 
(data not shown). Animals were separated into three sets. Trans-
fection cocktails were introduced via multiple ports, including 
those typically associated with viral infections such as HIV and 
HSV. Each animal was given an intravenous injection in the femo-
ral vein and subcutaneously; also, inoculants were introduced into 
the peritoneal cavity, applied into the pharynx, nasal cavity, and 
rectum. Animals in Set 1 (control) were inoculated with linearized 
pEGFP-N1 plasmid DNA in which the HCMV I.E. promoter se-
quence was interrupted by digestion with  Hin dIII, 5 µg of DNA in 
100 µL of PBS/10 mM MgCl 2 per site. Set 2 animals were inocu-
lated with a preformed complex of purifi ed rat LDL and pEGFP-
N1 plasmid, linearized using Stu I. Set 3 animals were inoculated 
using a cocktail mix containing human LDL and linearized pEGFP-
N1 plasmid (100 µg of LDL protein and 5 µg of DNA in 100 µL of 
PBS/10 mM MgCl 2 per site). One animal from each set was eutha-
nized as described above (Isolation of Plasma Lipoproteins sec-
tion) on days 2, 5, and 7; tissues were excised and immobilized in 
O.C.T. compound and frozen using liquid nitrogen. The immobi-
lized tissue samples were sectioned using a cryomicrotome. Sec-
tions (5–8 µm thick) were fi xed for 30 min in 4% paraformaldehyde 
and analyzed for expression of GFP by fl uorescent microscopy. 
Animals scheduled for day 9 study were spared, because GFP ex-
pression was not observed in tissues harvested on days 5 and 7. 
 In separate experiments performed at UTHSC, four animals 
were transfected with either pGL2-Control alone or pGL2- 
Control complexed to LDL, cationic liposome (Transfection Re-
agent 1), or to a mixture of LDL and liposome and distribution 
of the luciferase gene in rat tissues was determined by PCR. 
 Rats were anesthetized with ketamine/xylazine (200 mg/10 
mg per 1 kg animal weight injected intraperitoneally) and a small 
incision was made through the skin of the inner thigh to expose 
the femoral vein. Injection of plasmid DNA was made with a 30 
gauge needle directly into the femoral vein. After the injection, 
pressure was applied to the puncture to avoid leakage and was 
continued until coagulation occurred. The skin incision was 
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 Sequence comparison analysis 
 Highlighting group-related amino acids in sequence fi les 
discussed in Methods revealed the location of clusters and 
motifs that were then used to align multiple sequences. 
 Region 1, the N-terminal sequence of apo B100 
 Capsid proteins of the fl aviviruses and DNA binding do-
mains of  irf proteins are rich in arginine and lysine amino 
acids. Arg/Lys-rich clusters are located near the N-termini 
of apo B100,  hcv ,  ylfv ,  dng 1 – 4 , and  irf proteins 1, 2, 5, 6, 8, 
and 9. In the sequences of  irf proteins 3, 4, and 7 and  wnlv 
and  bvdv , Arg/Lys clusters are located distal to the fi rst 20 
N-terminal residues. 
 Flaviviruses are thought to gain cell entry via the LDL B/E 
receptor ( 24, 25 ). The well-established B/E receptor ligand 
region in apo E is an Arg/Lys-rich cluster,  0141 LRKLRK 0146 
quences containing these features were then aligned and group-
related amino acids in multiple sequences were highlighted to 
further assess similarity. Two regions in the apo B100 sequence 
were selected for these analyses: Region 1 spans the N-terminus 
from Glu 0013 to Pro 0140 and Region 2 includes residues Asp 3313 to 
Arg 3500 . Each of these apo B100 regions contains at least one 
basic amino acid cluster. Different options for multiple sequence 
alignment were also evaluated using T-COFFEE (http://www.
bioinformatics.nl/tools/t_coffee.html). 
 Sequence comparison was also performed using two recog-
nized algorithms for sequence similarity searches, SSEARCH and 
PSI-BLAST. The entire sequences of Regions 1 and 2 of apo 
B100, as well as their fragments and expanded versions, were 
used as query sequences. SSEARCH of UniProtein Knowledge-
base, and UniProtKB/SwissProt databases was performed at the 
EBI site (http://www.edi.ac.uk/Tools/fasta33/index.html) us-
ing all available BLOSUM matrices (BLOSUM 50, 62, and 80) 
and default or weaker gap penalties (e.g., BLOSUM 62 has -11/-1 
for gap opening/gap extension as default setting). PSI-BLAST 
searches were conducted at the NCBI website (http://blast.
nchi.nlm.nih.gov/Blast.cgi). Databases of various sizes were 
searched, each with various search settings such as scoring matrices 
(BLOSUM 45, 62, and 80) and PSI-BLAST thresholds. Several 
iteration steps (3–5 times) were performed until the search did 
not result in any new additional fi nds. 
 RESULTS 
 DNA-binding 
 Present studies expand data on the capacity of LDL 
to bind HCMV promoter-containing plasmids and to 
transfect cells in vitro ( 18, 20 ); also, the latter property is 
newly demonstrated in vivo. In  Fig. 1 (upper panel), DNA-
binding capacity of human lipoproteins, VLDL, LDL, and 
HDL, is illustrated. LDL samples from two donors are 
shown (donor A, lanes 1–5, and B, lanes 6–10); both sam-
ples had similar mobility in CBB-stained gel (middle 
panel) and bound the pCMV   -Gal plasmid in almost 
identical fashion (upper panel). VLDL, although a larger 
apo B100-containing particle, displays higher electropho-
retic mobility compared with LDL due to differences in 
both lipid and protein contents ( 6, 39 ). Results shown in 
Fig. 1 (lanes 14-15, donor B only) indicate that VLDL 
binds to plasmid DNA in a concentration-dependent man-
ner. Further, the mobility pattern for VLDL in the EMSA 
differs from the pattern seen for LDL. At lower VLDL con-
centrations, bound DNA is seen in a band of higher elec-
trophoretic mobility (lanes 12–13); the shift toward lower 
mobility region is observed at increased VLDL protein/
DNA ratio (lanes 14–15) in the upper panel. In separate 
experiments, high purity, delipidated apo E was used to 
determine whether it contributes to the VLDL/DNA bind-
ing. Apo E binding to plasmid DNA ( Fig. 1 , lower panel) 
suggests that both apo B100 and apo E may determine the 
observed EMSA pattern for these particles. 
 Only apo B100-containing lipoproteins bound DNA in 
our studies. HDL, which lacks apo B100, did not infl uence 
plasmid mobility, lanes 16–18. Protease-treated LDL lost 
its capacity to bind DNA in EMSA (not shown). Hence, 
apo B100 is essential for DNA binding to lipoproteins. 
 Fig.  1. EMSA of human lipoproteins binding to linearized pCMV 
  -Gal. Upper panel: Ethidium bromide-stained gel, 0.75% agarose 
in TA buffer, pH 7.6. Lanes 1–10: LDL binding to 1.0 µg of pCMV 
  -Gal linearized using  Hin dIII. Lanes 1–5, LDL from donor A, 2.5, 
5, 10, 20, and 30 µg by protein, respectively; lanes 6–10, LDL from 
donor B, same protein amount as in lanes 1–5. Lanes 11–15: VLDL 
(from donor B) binding to same plasmid DNA; 5, 10, 20, 30, and 60 
µg of VLDL protein, respectively. Binding of LDL and VLDL to 
DNA is evident by formation of lower-mobility band and decrease 
in the amount of free plasmid as the concentration of lipoproteins 
increases. HDL from donor B did not bind to the plasmid at 
amounts of 10, 20, and 40 µg of HDL protein (lanes 16–18). Plas-
mid DNA alone is shown in lane 19. Middle panel: The same gel 
stained with CBB dye. Bottom panel: Ethidium bromide-stained 
0.8% agarose gel is shown in the left image. Lane 1: DNA ladder; 
lane 2: 0.8 µg phMGFP plasmid; lanes 3–6: binding to the same 
amount of plasmid by 1.8, 3.6, 5.4, and 7.6 µg, respectively, of >95% 
pure, delipidated apo E; lane 7: 7.6 µg apo E alone. Image on right 
is the same gel stained with CBB. 
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 Apo E similarity to Flaviviridae capsid proteins 
 A sequence alignment comparison of the apo E se-
quence containing the B/E receptor ligand, residues 
Leu 151 to Arg 278 , and the sequences of the four versions of 
 dng was performed to identify analog elements. Results are 
presented in  Table 2 . The  dng1 and  dng3 proteins have 
three discrete Arg/Lys-rich cluster in their N termini, each 
containing a copy of the K/R-XX-K/R motif (underlined 
in columns 1 and 2). Additional analog sequences are 
highlighted in bold in column 2. A potential bipartite NLS 
sequence was identifi ed in the carboxy-terminal region of 
the apo E molecule (column 3,  Table 2 ). 
 In summary, the N-terminal region of apo B100, the 
LDL B/E receptor ligand region of apo E, capsid pro-
teins of the several fl aviviruses, and the DNA binding 
domain regions of the  irf proteins appear to be analogs 
of each other, which suggests similar functions. For 
apolipoproteins, these similarities mean potential DNA-
binding and nuclear translocation capacities. In turn, 
similarity of Flaviviridae capsid proteins to apolipopro-
teins may greatly facilitate ability of these viruses to pen-
etrate cells. 
 Region 2, the putative helicase domain of apo B100 
 The apo B100 sequence extending from Asp 3313 to Ser 3458 
was predicted to bind DNA and mediate cell entry due 
to the presence of both Arg/Lys-rich clusters and the ac-
cepted B/E receptor ligand sequence,  3353 KLEGTTRL-
TRKRGLKLA 3369 . Based on the apparent preferential 
binding of LDL to plasmids containing the HCMV IE2 pro-
moter ( 20 ), this region of the apo B100 sequence was com-
pared with the sequence of the HSV5 UL122 protein, which 
binds to the CMV promoter ( 36 ). The apo B100 Region 2 
sequence was also compared with the NS3 helicase of the 
 Flaviviridae viruses,  dng1 , wnlv , and  ylfv , because an Arg/
Lys-rich cluster was located within the NS3 sequence by 
highlighting of the arginine and lysine residues in their 
precursor polyprotein sequences. The sequence alignment 
comparison of the NS3 helicase domains of the HSV5 
UL122 and  Flaviviridae NS3 to the proposed analog se-
quence in apo B100 is presented in  Table 3 . Apo B100 (res-
idues 3316–3458) and UL122 (residues 276–420) share 
motifs KSS, LLSSSSSV, and GTTR. In column 3, a compari-
son of arginine/lysine-rich clusters of the NS3 helicases, 
e.g.,  1685 REAIKRKLRT in  dng1 , and the analog sequence in 
apo B100 LDL B/E receptor ligand,  3359 RLTRKRGLK, is 
shown. In the NS3 helicases of  dng ,  wnlv , and  ylfv , the  K XX R 
motif is part of the Walker A motif ( 34, 46 ), GXG K TR R . 
Analog sequences occur as GTT R LT R in apo B100 and as 
ASTGP R KK K in UL122 (Walker motifs are associated with 
nucleotide binding in kinases and helicases) ( 47 ). Flanking 
the Walker A motifs in the viral helicases are sequences of 
two   -sheet structures, e.g., QITVLDL and LRTAVLAP in 
 wnlv. These are conserved in analog sequences SSSVIDA 
and LKLATALS in apo B100. The hydrophobic stretch, 
 3367 KLATALSLSNKFV, which follows the receptor ligand 
in apo B100, may be a legitimate analog to the sequence 
 1691 KLRTLILAPTRVV in  dng1 and other  Flaviviridae heli-
cases ( 35 ). The sequence alignments in columns 4 and 5 
( 27 ). The critical residues in binding/docking to the 
receptor are lysine residues 0143 and 0146, which are 
located on the hydrophilic side of an amphipathic helix 
( 27 ). Replacing either lysine with arginine (as  R XXK or 
KXX R ) does not affect binding affi nity; however, arginine 
substitution of both sites ( R XX R ) reduces binding by 
almost 70% ( 27 ). 
 The R/K-X-X-R/K is a multi-functional motif (includ-
ing RXXR) essential in both protein-protein interactions, 
including nuclear entry (NLS sequences) and protein- 
nucleic acid interactions ( 40–43 ). A comparison of the R/K 
clusters in Region 1 of apo B100, fl aviviral capsid proteins, 
and  irf DNA binding domains is shown in  Table 1 . The 
N-terminal cluster of apo B100 contains three renditions 
of the R/K-XX-R/K motif as  R XX H ,  K XX R , and  H XX K 
(see column 1); apo E N-terminus has  H XX K , two  R XX R , 
and one  K XX K ; there are three copies in  hcv ( K PQ R , 
 R KT K ,  K TK R ); one as  R XX R in  ylfv ; and all versions of 
Dengue capsid proteins are replete with this motif, bipar-
tite NLS sequences, and the R/K-X-R/K-X-R/K motif. 
 Arginine, in  R X R X R and  R XX R motifs, is the predomi-
nant basic amino acid in the N-terminal clusters of the  irf 
proteins. Only the  R XX R low affi nity B/E receptor ligand 
motif is present in the N-termini of DNA binding domains 
of  irfs 5 , 6 , 8 , and  9 . The high-affi nity B/E receptor ligand 
motifs ( 27 )  K XX K ,  K XX R , and  R XX K , absent in the 
N-terminal R/K clusters of  irf proteins, are present in their 
DNA binding and NLS motifs located in the C-terminal 
region of these domains ( 44 ). 
 The motif K/R-XXX-K/R shown in column 3 and pres-
ent in the sequences of apo B100 Region 1,  bvdv ,  hcv , and 
 irf s is repeated several fold in the  irf proteins. Another mo-
tif that appears in most of these proteins is the       -K/R 
motif (  , hydrophobic residue); it is also highlighted in 
column 3. In  irf s, these motifs have been shown to interact 
with the backbone phosphate moieties of the nucleic acid 
( 45 ). 
 Analogs of the K/R-XXX-K/R motif, shown in column 
4, are part of the NLS sequence located before the metal-
binding sequence of the  irf proteins ( 45 ). The apo B100 
sequence, NPEGKALLK is very similar to the sequence 
QPEGRAWAQ in  hcv capsid protein. In  irf s, the NPEG ap-
pears as EPDP and is separated from the K/R-XXX-K/R 
motif by a tripeptide sequence, KTW, missing in apo B100, 
and two viral capsid proteins,  bvdv and  hcv . An analog of 
the apo B100 sequence, K KTKNS EEF, is contained in the 
 bvdv as T KSKNT QDG and as “ NKSS EF” in  irf 9. 
 A PG motif is also located near the N termini of apo 
B100,  hcv , and  irf proteins 1, 2, 4, 5, 6, 8, and 9 but not 3 
and 7 (column 2,  Fig. 1 ). The PG motif was used as a refer-
ence point for alignment and served in locating clusters of 
polar amino acids, also highlighted in column 2. 
 In  hcv , the capsid/core protein is cleaved within a short 
stretch of hydrophobic amino acids,  0175 SIFLLALLS 0183 ( 26 ). 
Analog sequences are also present in other fl aviviruses. 
Three motifs contained in this region of the  hcv capsid pro-
tein, shown in column 5, are also apparent in apo B100, 
 0132 GIISALLVP 0140 (with 2 potential cleavage sites),  0148 QV-
LFL 0152 , and  0158 NCS 0160 (a potential N-glycosylation site). 
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proteins included in  Tables 1 and 3 , and these resulted in 
the detection of viral sequences only. 
 LDL-mediated transfection of cells in culture 
 Different cell types, including HeLa, Hep G2, CHO, and 
NIH3T3, were transfected using LDL mixed with BOBO-1-
labeled plasmid DNA containing the HCMV promoter as 
described in Methods. Typically, LDL-mediated transfection 
of HeLa, Hep G2, and NIH3T3 cells occurred rapidly after 
upregulation of the B/E-receptor via incubation of cells in 
FBS-free medium for 2–4 h; fl uorescence was observed within 
minutes after LDL/BOBO-1-DNA mix is added to the me-
dium. Almost 100% of HeLa cells shown in  Fig. 2A were 
transfected within 30–45 min, and BOBO-1 fl uorescence is 
seen predominantly in cell nuclei. In CHO cells, transfection 
occurred over an extended period for hours, not minutes 
( Fig. 2B ). Also, fl uorescence appeared to remain in the 
cytoplasm with little to none in nuclei. Few to no cells were 
transfected in all cell types by naked DNA ( Fig. 2C ). 
 In Hep G2 cells, two fl uorescence dyes (CM-DiI for 
transfection agents, BOBO-1 for pCMV   -Gal DNA) were 
used to compare Lipofectin- and LDL-mediated transfec-
tion ( Fig. 2D–K ). All images were taken at 3 h after trans-
fection. This time point was chosen for optimal transfection 
results using Lipofectin, which was delayed compared with 
weakly suggest similarities between these proteins. Notably, 
the DEAD motif typical of helicases is not conserved in apo 
B100 but may be represented as DFNS. 
 Our method for sequence comparison analysis identi-
fi es weakly similar sequences that may be analogs of known 
proteins and therefore may perform similar functions. 
This algorithm reveals that apo B100 Region 1 sequence 
shares about 46% similarity and 22% identity with the DNA 
binding domains of the  irf proteins and about 25% similar-
ity and <10% identity with the viral capsid proteins. Se-
quence similarities between apo E and the  irf proteins 
were <25%. The apo E sequence spanning  0155 Leu and 
 0248 Asp is 55% similar to the fi rst 100 N-terminal resi-
dues of  dng1. 
 Similarity searches using SSEARCH and PSI-BLAST al-
gorithms were performed to probe the protein sequence 
databases for potential homologies and to further substan-
tiate our observations. Although these algorithms fi nd sev-
eral matches to RNA- and DNA-binding proteins in the 
SwissProtein database, the E-value range for these matches 
is 1 < E < 10 and is therefore not considered highly signifi -
cant. All statistically signifi cant homologs belong to several 
families of lipoprotein transport proteins of animals, 
and no signifi cant viral homologs were revealed. Similar 
searches were performed with input sequences of the viral 
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these experiments. Fluorescence was not seen in controls 
where naked DNA was used (not included). Merged over-
lays of brightlight and fl uorescence images in  Fig. 2L 
show GFP expression in MCF7 cells at 2 h after transfec-
tion. Loci of apparent GFP synthesis are visible on the 
periphery of nuclei. GFP expression was seen in <10% 
CHO cells examined (Fig. 2M). Intense and uniform 
distribution of GFP expression was seen in NIH/3T3 cells 
at 18 h (Fig. 2N) and in HeLa cells at 1 h (Fig. 2O) and 
18 h (Fig. 2P) post transfection. Nuclei devoid of GFP 
are clearly visible (Fig. 2P). In summary, images in  Fig. 2 
unambiguously demonstrate successful LDL-mediated 
intracellular delivery and nuclear translocation of dye-
labeled DNA as well as GFP expression in transfected 
cells in vitro. 
 Animal studies 
 Rats inoculated with rat or human LDL/pEGFP-N1 mix-
tures via multiple ports were euthanized on days 2, 5, and 
7 (Methods). However, GFP expression was not observed 
in tissues harvested on days 5 and 7. Photographs taken 
LDL-mediated DNA delivery. Uptake of label was not seen 
in cells given DNA only (not shown). Extracellular loca-
tion of fl uorescence can be seen in cells treated with la-
beled Lipofectin alone (Fig. 2D). These extracellular 
aggregates may result from Lipofectin interaction with cell 
debris or may form before its cell entry. In contrast, signal 
from labeled LDL is typically seen associated with cells 
(Fig. 2H). Micrographs E–G and I–K illustrate cellular up-
take of dual labeled Lipofectin/DNA and LDL/DNA 
complexes, respectively. Red fl uorescence of labeled Lipo-
fectin (Fig. 2E) in the cytoplasm is more intense and not 
in discrete loci as seen for labeled LDL (Fig. 2I). Little or no 
red fl uorescence is present in the nuclear spaces. BOBO-1 
green fl uorescence is seen in nuclei and cytoplasm of cells 
transfected with Lipofectin/DNA (Fig. 2F) and LDL/DNA 
(Fig. 2J). Dual color images (Fig. 2G, K) further empha-
size colocation and separation of dyes suggested by the 
monochrome images. 
 LDL-mediated delivery of pEGFP-N1 DNA to cells was 
tested further by monitoring GFP expression in different 
cell types ( Fig. 2 , right panel, L–P). No dyes were used in 
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 Fig.  2. LDL-mediated transfection of mammalian cell types with plasmid DNA containing HCMV promoter. Upper-left  panel: Images 
A–C: LDL-mediated transfection of HeLa (A) and CHO cells (B) with BOBO-1-labeled pCMVTNT. HeLa cells given labeled plasmid 
alone are in C. Lower-left panel: Images D–K: HepG2 cells transfected using Lipofectin (D–G) and LDL (H–K) in dual label experiment. 
BOBO-1-labeled, linearized pCMV   -Gal combined with CM-DiI-labeled transfection agent was given toHepG2 cells (Methods). Images 
D (Lipofectin) and H (LDL) are brightlight and FITC fi lter overlay (merged) images of HepG2 cells treated with CM-DiI-labeled trans-
fection agent alone. Images E–G show cells incubated with CM-DiI-Lipofectin/BOBO-1-pCMV  -Gal, and images I–K show cells treated 
with CM-DiI-LDL/BOBO-1-pCMV   -Gal. Images E (Lipofectin) and I (LDL) obtained with the FITC fi lter show location of labeled 
transfection agents only. Images F (Lipofectin) and J (LDL) obtained using the GFP fi lter cube show labeled-DNA loci. Images G and K 
are merged images (D/E, Lipofectin) and (I/J, LDL) that show coloci and separate loci of labeled transfection agents and DNA. Right 
panel: Images L–P: GFP was expressed in a variety of cell types after LDL-mediated transfection with pEGFP-N1 plasmid DNA. Images 
are merged overlays of brightlight and fl uorescence micrographs. L: MCF7, and M: CHO cells at 2 h after transfection. N: NIH/3T3 cells 
at 18 h after transfection. O, P: HeLa cells at 1 h (O) and 18 h (P) post transfection. GFP expression appears as pronounced green 
fl uorescence. 
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acids to nonpolar, hydrophobic amino acids ( 4 ). The N 
terminus, residues 0012 thru 0160 (Region 1), and the 
known B/E receptor ligand region, residues  3313 Asp thru 
Ser 3458 (Region 2), meet these criteria. 
 In EMSA studies, synthetic peptides B1-1 ( 0014 Lys-Glu 0054 ) 
and B1-2 ( 0055 Leu-Ala 0096 ) were shown to bind phMGFP 
DNA in the presence of 10 mM MgCl 2 ( Fig. 4 ). Electro-
phoresis was performed in a 0.8% agarose and TA buffer. 
Results are shown in image A: for plasmid only, lane 1; 
plasmid plus 3, 6, and 12 µg of each peptide, B1-1 ( 0014 Lys-
Glu 0054 ), lanes 2, 3, and 4, respectively; B1-2 ( 0055 Leu-
Ala 0096 ), lanes 5–7; B2-1 ( 3313 Asp-Glu 3355 ), lanes 8–10; B2-2 
( 3356 Gly-Thr 3431 ), lanes 11–13; B1-1/B1-2 (R1) mix, 8 µg 
each, lane 14; and B2-1/B2-2 (R2) mix, 8 µg each, lane 15. 
Peptides visualized with Coomassie Blue dye in the gel 
are in image B. Results for peptide B2-3 ( 3358 Thr-Leu 3373 ), the 
known B/E receptor ligand, mixed with plasmid are shown 
in image C, DNA alone (lane 16), and DNA plus 10 µg 
peptide (lane 17). 
 Cocktails of B1-1/B1-2, Region 1, mixed with phMGFP 
were shown to deliver BOBO-1-labeled DNA to precondi-
tioned HeLa cells within 1 h after addition of peptides/
DNA complex to the medium ( Fig. 5A–H ). As time pro-
gressed, fl uorescent, amorphous cell debris was observed. 
Cell experiments using peptides alone confi rmed the cyto-
toxicity of Region 1 peptides ( Fig. 5I, J ), as indicated by 
the accumulation of Trypan blue dye in the cell culture 
treated with these peptides. 
 Synthetic peptides B2-1 ( 3313 Asp-Glu 3355 ), B2-2 ( 3356 Gly-
Thr 3401 ), and B2-3 ( 3358 Thr- Leu 3373 ) were also shown to 
bind phMGFP DNA in the presence of 10 mM MgCl 2 ( Fig. 
4 ). Binding of the B2-3 peptide appeared to be weak, re-
sulting only in a smearing appearance of the plasmid band. 
Cocktails containing peptides B2-2 and B2-3 with DNA 
were ineffective in transfecting HeLa cells (results not in-
cluded). Further, these peptides were shown to be noncy-
totoxic ( Fig. 5K, L ). 
 DISCUSSION 
 LDL and VLDL transport lipids in the plasma and are 
characterized by apo B100 as their major protein. We have 
demonstrated plasmid DNA-binding capacity for these li-
poproteins and that DNA bound to LDL is transferred to 
the cell nucleus. Our results confi rm that LDL is an effec-
tive transfection vector in vivo and in vitro. Lp (a), another 
apo B 100-containing particle that may be present in small 
quantities in the LDL fraction with buoyant density < 1.050 
g/ml ( 48 ), was not shown to possess DNA-binding capacity 
( 20 ). Apo (a), the massive, hydrophilic molecule cova-
lently linked and noncovalently attached to apo B100 to 
form Lp (a), contains only one Arg/Lys-rich cluster in the 
kringle domain in the single copy of kringle type 11 and 
two in the putative serine protease domain ( 49, 50 ). Krin-
gle types 1–10 in apo (a) are similar to plasminogen krin-
gle 4 ( 49 ) and are devoid of basic amino acid clusters and 
motifs suggestive of nucleic acid binding or nuclear trans-
location. The noncovalent interactions between apo (a) 
immediately after collection of tissue sections on day 2 are 
shown in  Fig. 3 . In the top row, GFP fl uorescence is seen 
in the basal cell layer of the stratifi ed squamous epithe-
lium of the esophagus ( Fig. 3 A). No fl uorescence is visible 
in the lamina propria region located at the lower portion 
of the image. GPF fl uorescence is also seen in the spinal 
cord ( Fig. 3C ), lung ( Fig. 3 E), liver ( Fig. 3 G), and heart 
( Fig. 3 I) in animals given rat LDL/pEGFP-N1 plasmid 
cocktail. Fluorescence was not detected in samples from 
both large and small intestine, brain, and dorsal aorta (im-
ages not included). The intense fl uorescence seen in the 
spiral and tubular structures in the lung image ( Fig. 3 E) 
and the endothelium of the hepatic vein ( Fig. 3 G) was a 
matter of concern, because these structures are character-
ized by elastic laminae, which are known to autofl uoresce. 
However, images of tissues obtained from control animals 
treated only with the  Hin dIII-cut pEGFP-N1 ( Fig. 3B , 
esophagus; D, brain; F, lung; H, liver; J, heart) showed no 
or low intensity fl uorescence. In the rat inoculated with 
human LDL/pEGFP-N1 complex, intense fl uorescence is 
visible in the myocardial tissue ( Fig. 3K ). Results obtained 
from other tissues from this animal were inconclusive. 
 Separate experiments were conducted to compare 
tissue distribution of the luciferase gene delivered as 
pGL2-Control DNA alone or complexed to LDL, cationic 
liposome, or to a mixture of LDL and liposome. Each rat 
was given one injection of DNA/transfection agent mix at 
a single site (see Methods). DNA extracted from each tis-
sue was analyzed by PCR using luciferase-specifi c primers 
( Fig. 3 , lower panel). A qualitative comparison of these re-
sults is shown in  Table  4 . Briefl y, pGL2-Control vector 
alone appears to transfect liver, brain, and spleen at barely 
detectable levels. Whether the DNA binds to LDL particles 
present in the rat’s plasma was not determined in these 
studies. LDL-mediated delivery was highly effective in the 
kidney and spleen, somewhat effective in brain and heart, 
but negative results are seen in the lungs and liver. The 
difference between results obtained in LDL-mediated 
transfection with GFP gene and the luciferase gene, both 
driven by the CMV promoter, may be attributed to different 
inoculation methods (multiple sites of inoculation/applica-
tion in the former study vs. single site injection in the latter 
experiment). The liposome-plasmid complex was highly ef-
fective in liver and visibly effective in heart, transfected lung, 
kidney, and spleen at lower levels, but was negative in brain. 
The LDL/Liposome mix was highly effective in delivery of 
the plasmid to the heart and lung, less effective in spleen, 
only slightly effective in brain, and negative in liver and kid-
ney. These preliminary results confi rm that LDL particles 
are useful transfection vectors in vivo. 
 Synthetic peptide studies 
 Synthetic peptides of apo B100 Regions 1 and 2, pre-
sented in  Tables 1 and 3 , were obtained to evaluate the 
role of apo B100 in nucleic acid-binding, transport, and 
delivery. Two additional criteria were important in select-
ing these regions: presence of an apo E receptor ligand 
analog sequence and solubility (hydrophilicity and hydro-
phobicity), based on ratio of charged and polar amino 
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and known nucleic acid-binding domains of transcriptional 
regulators ( irf proteins and capsid/core proteins of Flavi-
viruses) provide an explanation for the capacity of LDL to 
bind DNA and RNA ( 17–23 ). These sequence similarities 
and experimental results strongly suggest that the fi rst 160 
residue N-terminal region of apo B100 and LDL receptor 
ligand region of apo E have functions of nucleic acid bind-
and apo B100 that probably involve lysine residues on the 
apo B100 ( 50 ) may render nucleic acid binding regions 
inaccessible. Hence, the Lp (a) particle may not have a 
role in the transport and delivery of nucleic acids. 
 LDL transfection capacity is likely based on apo B100, 
which provides the particle with DNA binding and cell en-
try potential. Sequence similarities in apo B100, apo E, 
 Fig.  3. GFP expression and tissue distribution in rat. Top panel: GFP was expressed in esophagus (A, basal cells of stratifi ed squamous epi-
thelium), spinal cord (C), lung (E), liver (G), and heart (I, rat LDL-mediated transfection, and K, human LDL-mediated transfection). 
Frozen sections (4–8 µm thick) were obtained 2 days after the animals were given a mixture of LDL and linearized pEGFP-N1 DNA (images 
A, E, I, C, G, K) via multiple ports as described in Methods. GFP expression is not seen in control animals given interrupted plasmid DNA 
alone (B, D, F, H, J, L). Bottom panel:  Distribution of luciferase gene in rat tissues. Lanes 1–6 show luciferase-specifi c 800 bp band in heart, 
liver, lung, brain, kidney, and spleen, respectively. Rats were transfected using pGL2-Control plasmid alone, or cocktails of rat LDL/pGL2-
Control, Liposome/pGL2-control, and rat LDL/Liposome/pGL2-Control plasmid. DNA was extracted from rat tissues on day 2 after 
transfection and assayed using PCR with luciferase-specifi c primers 5 ′ agcaactgcataaggctatg and 3 ′ gttggtactagcaacgcact. 
 TABLE 4. Post-transfection distribution of the reporter genes in rat tissues 
Tissue
pGL2 Plasmid
only
LDL/pGL2
Complex
Liposome/pGL2 
complex
LDL/liposome/ pGL2 
complex
LDL/pEGFP-N1
complex*
Heart Negative Positive Positive Highly positive Highly positive
Liver Slightly positive Negative Highly positive Negative Highly positive
Lung Negative Negative Slightly positive Highly positive Highly positive
Brain Slightly positive Positive Negative Slightly positive Negative
Kidney Negative Highly positive Slightly positive Negative Not examined
Spleen Slightly positive Highly positive Slightly positive Positive Not examined
Esophagus Not assayed Not assayed Not assayed Not assayed Positive
Spinal Cord Not assayed Not assayed Not assayed Not assayed Positive
Rats were transfected in vivo with pGL2-Control plasmid, alone (column 2) or complexed to LDL (column 3), 
liposome (column 4), or to LDL/liposome mix (column 5). Presence of luciferase gene was determined by PCR in 
heart, liver, lung, brain, kidney, and spleen tissues (column 1) of the rat on day 2 after transfection. GFP expression 
in tissues of the rat transfected with pEGFP-N1 plasmid/LDL mix (column 6) was determined on day 2 and was 
based on green fl uorescence in frozen section of different tissues. The data are illustrated in  Fig. 3.  * Inoculant was 
administered at multiple sites.
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regulate transcription ( 52–55 ). In the fl aviviruses, once 
the polyprotein is expressed, the capsid proteins are 
cleaved by an endopeptidase at one of two dipeptide mo-
tifs of small hydrophobic amino acids such as Leu-Leu 
( 26 ). Analogs of these dipeptide motifs are also present in 
a like-region of apo B100 as Ile-Ile and Leu-Leu. It is inter-
esting to consider a similar mechanism is employed to 
release the N-terminal region of apo B100 for similar 
functions. Another property reported for the  wnlv capsid/
core protein is cytotoxicity ( 52, 56–58 ). This effect was also 
observed with the B1-1/B1-2 peptides mix on HeLa cells. 
One possible scenario would be that the N-terminal region 
of apo B100 is cleaved so that it may compete with viral 
capsid proteins for the nucleic acid and/or kill infected 
cells to suppress the infection process. 
 The synthetic peptides of the apo B100 region 2 were 
shown to bind DNA in EMSA. Region 2 sequence is similar 
to HSV5 UL122 helicase and  Flaviviridae NS3 helicases and 
contains several analog motifs present in these viral pro-
teins. Surprisingly, these peptides were ineffective in deliv-
ery of DNA to the cells despite the presence of the know 
B,E-receptor-binding ligand, possibly due to blocking of 
the receptor ligand site by DNA or inadequate conforma-
tion for docking with the receptor. 
 In summary, apo B100 and apo E, constituent pro-
teins in LDL and VLDL, share many similarities with the 
fl aviviral proteins that may be construed as analogs. Sig-
nifi cant viral homologs were not found in the databases 
using recognized search algorithms and therefore lessen 
the possibility that these apolipoproteins are viral in ori-
gin. These apolipoproteins may have evolved as part of 
the im mune system to address and/or eliminate viral 
(microbial) nucleic acids from circulation. Alterna-
tively, we can consider also that fl aviviruses may have 
evolved to mimic apo B100 and apo E domains to gain 
cell entry and evade the immune system of the host. 
Viral genomes are known to evolve faster than the 
ing. Synthetic peptides covering part of this apo B100 
region, Region 1, bind plasmid DNA and substantiate this 
function to a degree, with the caveat that ligand specifi city 
and peptide conformation are undetermined. Region 1 
peptides also mediate cell entry for plasmid DNA, presum-
ably via the B/E receptor and/or through the mechanism(s) 
used by Arg/Lys-rich cell-penetrating peptides ( 51 ). NLS 
sequence motifs are characterized by Arg/Lys-rich clusters, 
as in the DNA binding domains of most  irf proteins and in 
the capsid/core proteins of  hcv and other  Flaviviridae vi-
ruses. Hence, apo B100 Region 1 contains motifs that im-
part nucleic acid binding, mediate cell uptake, and are 
apparently involved in transferring DNA into the cell 
nucleus. 
 Several studies suggest that  Flaviviridae viruses may gain 
cell entry via the B/E receptor ( 24–26, 52 ). This mecha-
nism is thought to involve the E1 and E2 structural pro-
teins of the virus ( 26 ). Although one LRK motif occurs in 
envelope proteins of  dng1 and  dng3 , our examination of 
the primary structures of  dng1 envelope proteins did not 
reveal a complete apo E receptor ligand Arg/Lys-rich clus-
ter similar to those contained in its capsid protein. How-
ever, four additional analogs of the  K/R- XX- K/R are 
contained within the sequence spanning  0561 Gly to  0695 Leu 
of the  dng1 polyprotein sequence. In  hcv and the four ver-
sions of  dng , Arg/Lys-rich clusters containing multiple 
copies of the  K/R- XX- K/R motif similar to those in the 
apo E receptor ligand sequence are located near the N 
termini of the capsid proteins. In  wnlv and  ylfv , the motifs 
are also located in the capsid proteins but are distal to the 
N terminus. It is therefore possible that cell entry is medi-
ated by capsid proteins as well, and the almost ubiquitously 
expressed LDL B/E receptor may enhance viral infectivity 
and viability. 
 Flaviviral capsid proteins are multi-functional proteins, 
i.e., they bind nucleic acids, translocate nucleic acids to 
cell nucleus, have a role in dimerization of viral RNA, and 
 Fig.  4. EMSA of Apo B100-derived peptides and 
phMGFP. Sample cocktails were prepared using 0.42 
µg of phMGFP plasmid and increasing quantities of 
each peptide derived from Region 1 ( 0014 Lys-Ala 0096 ) 
and Region 2 ( 3313 Asp-Thr 3431 ) of apo B100, as well as 
combinations of peptides derived from the same re-
gion. Amino acid sequences of the peptides are listed 
in  Table 2 (Region 1) and  Table 3 (Region 2). Elec-
trophoresis was performed in a 0.8% agarose and TA 
buffer. A: lane 1: plasmid only; lanes 2, 3, and 4: plas-
mid plus 3, 6, and 12 µg, respectively, of peptide B1-1 
( 0014 Lys-Glu 0054 ); lanes 5, 6, and 7: plasmid plus 3, 6, 
and 12 µg, respectively, of peptide B1-2 ( 0055 Leu-
Ala 0096 ); lanes 8, 9, and 10: plasmid plus 3, 6, and 12 
µg, respectively, of the peptide B2-1 ( 3313 Asp-Glu 3355 ); 
lanes 11, 12, and 13: plasmid plus 3, 6, and 12 µg, 
respectively, of peptide B2-2 ( 3356 Gly-Thr 3431 ); lane 
14: plasmid plus B1-1/B1-2 (R1) mix, 8 µg each; lane 
15: plasmid plus B2-1/B2-2 (R2) mix, 8 µg each. B: 
pCMVTNT DNA, 1 µg alone (lane 16) and mixed 
with peptide B2-3 ( 3358 Thr-Leu 3373 ), 10 µg (lane 17). 
C: Same gel, lanes 1–15, stained with CBB. 
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ing to speculate that LDL may be also binding in vivo to 
circulating nucleic acids in plasma, which are present under 
normal conditions and are elevated in several diseases in-
cluding acute infl ammation and cancer ( 59–62 ). The role 
played by LDL and VLDL in the dissemination of  hcv geno-
mic RNA has been established by other investigators ( 16, 
17, 19 ), and binding of LDL to genomic DNA was reported 
previously ( 18, 20, 23 ). Combined with the capacity of LDL 
to transfect different cell types and tissues, these observa-
tions suggest that perhaps LDL, and possibly VLDL, play a 
similar role in the mechanisms of metastatic disease. 
human genome. This ability paired with typically large 
population sizes can result in a fast selection of viral 
protein patterns that are able to mimic LDL receptor-
binding motifs. 
 We surmise that the transport of nucleic acids by LDL 
may occur naturally and may be an essential function. Lip-
ids may mediate the conformation state of the apo B100 for 
addressing a wide spectrum of nucleic acids as well as inter-
actions with proteins. A function of apo B100- and apo 
E-containing particles may be in removing viral or other 
microbial nucleic acid debris from circulation. It is interest-
 Fig.  5. Synthetic peptide mediated transfection of HeLa cells. Top panel: Synthetic peptide mediated 
transfection of HeLa cells with BOBO-1-labeled phMGFP plasmid. Dye-labeled plasmid DNA complexed to 
apo B100-derived peptides was used to transfect HeLa cells grown in DMEM medium as described in Meth-
ods. All frames show a merged overlay image of the fl uorescence micrograph and the corresponding phase 
contrast version. Frames  A thru  C show cells transfected using cocktails of synthetic peptides B1-1 and B1-2 
( Table 2 ) derived from N-terminal region of Apo B100 mixed with 1.0   g BOBO-1-labeled phMGFP plasmid 
DNA: A: 1.5 nmol of B1-1 and 1.9 nmol of B1-2 plus plasmid; B: 5.9 nmol of B1-1 and 7.5 nmol of B1-2 plus 
labeled plasmid; C: 15 nmol of B1-1 and 19 nmol of B1-2 plus labeled plasmid. All transfection experiments 
were conducted in 400   l of DMEM. Enlarged cut-out images in inserts D–H show intracellular loci of label. 
All images were obtained using a Zeiss Axiovert 25 scope and the Optronics MicroFire CCD camera. Bottom 
panel: Cytotoxic effects of peptides B1-1 and B1-2 on HeLa cells are demonstrated using Trypan Blue dye . 
Cytotoxicity caused by mixtures of synthetic peptides B1-1 and B1-2, 4 µg each peptide (frame I) and 10 µg 
each peptide (frame J), added to preconditioned HeLa cells in DMEM. In contrast, no cytotoxicity is seen 
for HeLa cells treated similarly with mixtures containing the same quantities of synthetic peptides B2-1/
B2-2, frames K and L, respectively. 
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Changes in lipid content, chemical modifi cations of apo 
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 LDL and peptides derived from the apo B100 have great 
potential as nucleic acid transport and delivery vehicles 
with applications in gene replacement therapies, DNA vac-
cines, rapid creation of transgenic animals, and cell biore-
actors in the production of pharmaceutical proteins. LDL 
and VLDL are the only delivery nanoparticles that can be 
used in autologous formulations. Unlike viral or synthetic 
vectors and cell penetrating peptides ( 63 ), autologous 
LDL will not elicit an immune response. LDLs are easily 
purifi ed and can be readily stored for long periods in liq-
uid nitrogen. These naturally occurring particles can be 
exploited in the development of accurate gene replace-
ment formulations.  
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